289 related articles for article (PubMed ID: 12029284)
1. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
Kawasaki G; Kato Y; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
[TBL] [Abstract][Full Text] [Related]
2. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer.
Vigneswaran N; Zhao W; Dassanayake A; Muller S; Miller DM; Zacharias W
Hum Pathol; 2000 Aug; 31(8):931-7. PubMed ID: 10987253
[TBL] [Abstract][Full Text] [Related]
3. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
4. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
Niedergethmann M; Wostbrock B; Sturm JW; Willeke F; Post S; Hildenbrand R
Pancreas; 2004 Oct; 29(3):204-11. PubMed ID: 15367886
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D, B and L circulating levels as prognostic markers of malignant progression.
Tumminello FM; Leto G; Pizzolanti G; Candiloro V; Crescimanno M; Crosta L; Flandina C; Montalto G; Soresi M; Carroccio A; Bascone F; Ruggeri I; Ippolito S; Gebbia N
Anticancer Res; 1996; 16(4B):2315-9. PubMed ID: 8694562
[TBL] [Abstract][Full Text] [Related]
8. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer.
Castiglioni T; Merino MJ; Elsner B; Lah TT; Sloane BF; Emmert-Buck MR
Hum Pathol; 1994 Sep; 25(9):857-62. PubMed ID: 8088759
[TBL] [Abstract][Full Text] [Related]
10. Processing of cathepsins L, B and D in psoriatic epidermis.
Kawada A; Hara K; Kominami E; Hiruma M; Noguchi H; Ishibashi A
Arch Dermatol Res; 1997 Jan; 289(2):87-93. PubMed ID: 9049042
[TBL] [Abstract][Full Text] [Related]
11. Expression of cathepsins B, H, and L and their inhibitors as markers of transitional cell carcinoma of the bladder.
Staack A; Tolic D; Kristiansen G; Schnorr D; Loening SA; Jung K
Urology; 2004 Jun; 63(6):1089-94. PubMed ID: 15183956
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer.
Harbeck N; Alt U; Berger U; Kates R; Krüger A; Thomssen C; Jänicke F; Graeff H; Schmitt M
Int J Biol Markers; 2000; 15(1):79-83. PubMed ID: 10763146
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.
Thomssen C; Schmitt M; Goretzki L; Oppelt P; Pache L; Dettmar P; Jänicke F; Graeff H
Clin Cancer Res; 1995 Jul; 1(7):741-6. PubMed ID: 9816040
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Kos J; Skrk J
Clin Cancer Res; 2000 Mar; 6(3):1052-62. PubMed ID: 10741734
[TBL] [Abstract][Full Text] [Related]
15. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cells.
Nagaraj NS; Zacharias W
Toxicol Lett; 2007 Apr; 170(2):134-45. PubMed ID: 17399918
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters.
Adenis A; Huet G; Zerimech F; Hecquet B; Balduyck M; Peyrat JP
Cancer Lett; 1995 Sep; 96(2):267-75. PubMed ID: 7585467
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma of the vulva. Expression of tumor proteases cathepsin-D and pro-cathepsin-L.
Hantschmann P; Beysiegel S; Kurzl R
J Reprod Med; 1998 Nov; 43(11):933-42. PubMed ID: 9839260
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
Kawasaki G; Yoshitomi I; Yanamoto S; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):717-23. PubMed ID: 12464897
[TBL] [Abstract][Full Text] [Related]
20. Expression of cathepsins in dermal fibrous tumors: an immunohistochemical study.
Thewes M; Engst R; Boeck K; Ring J
Eur J Dermatol; 1998 Mar; 8(2):86-9. PubMed ID: 9649659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
